Pharmacology of emerging novel platelet inhibitors

被引:76
作者
Angiolillo, Dominick J. [1 ]
Capranzano, Piera [1 ]
机构
[1] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA
关键词
D O I
10.1016/j.ahj.2008.06.004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A number of promising antiplatelet therapies currently in advanced clinical testing offer hope for improving cardiovascular outcomes in patients with acute coronary syndromes and those undergoing percutaneous interventions. We review the preclinical pharmacology and selected ongoing clinical trials of promising novel platelet inhibitor therapies.
引用
收藏
页码:S10 / S15
页数:6
相关论文
共 23 条
[1]   PARticipation in inflammation [J].
Coughlin, SR ;
Camerer, E .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (01) :25-27
[2]  
Derian CK, 2003, EXPERT OPIN INV DRUG, V12, P209
[3]   Cytochrome P450 3A inhibition by ketoconazole affects prasugrel and clopidogrel pharmacokinetics and pharmacodynamics differently [J].
Farid, N. A. ;
Payne, C. D. ;
Small, D. S. ;
Winters, K. J. ;
Ernest, C. S., II ;
Brandt, J. T. ;
Darstein, C. ;
Jakubowski, J. A. ;
Salazar, D. E. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (05) :735-741
[4]   The disposition of prasugrel, a novel thienopyridine, in humans [J].
Farid, Nagy A. ;
Smith, Richard L. ;
Gillespie, Todd A. ;
Rash, T. James ;
Blair, Patrick E. ;
Kurihara, Atsushi ;
Goldberg, Mark J. .
DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) :1096-1104
[5]  
Gretle DD, 2007, J AM COLL CARDIOL, V49, p326A
[6]  
Huang JB, 2000, J PHARMACOL EXP THER, V295, P492
[7]  
Humphries RG, 2000, HAEMATOLOGICA S, V85, P91
[8]   Antagonists of the platelet P2T receptor:: A novel approach to antithrombotic therapy [J].
Ingall, AH ;
Dixon, J ;
Bailey, A ;
Coombs, ME ;
Cox, D ;
McInally, JI ;
Hunt, SF ;
Kindon, ND ;
Teobald, BJ ;
Willis, PA ;
Humphries, RG ;
Leff, P ;
Clegg, JA ;
Smith, JA ;
Tomlinson, W .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (02) :213-220
[9]  
KOGUSHI M, 2007, J THROMB HAEMOST S1, V5
[10]  
Kosoglou T, 2005, CIRCULATION S, V112, pII